Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
Objectives We identified factors associated with thromboembolic and bleeding events in two contemporary cohorts of anticoagulated patients with atrial fibrillation (AF), treated with either vitamin K antagonists (VKA) or non-VKA oral anticoagulants (NOACs).Design Prospective, multicentre observation...
Saved in:
Main Authors: | Raffaele De Caterina, Kurt Huber, Richard Schilling, Miklos Rohla, Thomas W Weiss, Ladislav Pecen, Giuseppe Patti, Jolanta M Siller-Matula, Renate B Schnabel, Dipak Kotecha, Markus Lucerna, Paulus Kirchhof |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-03-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/9/3/e022478.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pre-existing atrial fibrillation and risk of arterial thromboembolism and death following pneumonia: a population-based cohort study
by: Reimar Wernich Thomsen, et al.
Published: (2014-11-01) -
Detecting Atrial Fibrillation Using Smartwatches
by: Agnieszka Kulczycka-Rowicka, et al.
Published: (2025-02-01) -
Prospects of oral anticoagulant therapy in patients with atrial fibrillation and chronic anemia: a narrative review
by: Tatyana S. Degtyareva, et al.
Published: (2024-12-01) -
Japanese Patients’ and Physicians’ Preferences for Anticoagulant Use in Atrial Fibrillation: Results from a Discrete-choice Experiment
by: Ken Okumura, et al.
Published: (2015-06-01) -
Commentary: Oil and gas development exposure and atrial fibrillation exacerbation: a retrospective study of atrial fibrillation exacerbation using Colorado's all payer claims dataset
by: Judy Wendt Hess
Published: (2025-02-01)